There have been many figures bandied around, but one that sticks in my mind is ropren sales being worth $50 million in russia alone within next 2-3 years. lets assume this all goes to the bottom line.
This being the case would set market cap at 1 billion on PE of just 20. Depending on current "actual" market cap, that would put the SP between $5-10.
Now if Ropren gets sold elsewhere, and obviously supply can keep up, SP figure would be multiples of this.
Please correct me or point out anything wrong, my calculations are not dependable! Any way you look at it, SP still a bargin. Time to revise your buy Tharlow...
- Forums
- ASX - By Stock
- SLA
- big buy order
big buy order, page-19
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review